소포 림프종에 동반된 강직성 척추염 1예 = A Case of Ankylosing Spondylitis with Follicular Lymphoma

국문 초록 (Abstract)

강직성 척추염은 류마티스관절염처럼 만성적인 염증성관절 질환이지만 이전 연구들에서 강직성 척추염은 다른 자가면역 질환과 달리 림프종의 발생률을 의미 있게 증가 시키지는 않는 것으로 보고되었다. 국내에서 비호지킨 림프종과 강직성 척추염이 함께 발병한 증례가 보고된 적이없어, 비호지킨 림프종의 일종인 소포림프종으로 치료 중 강직성 척추염이 진단되어 비스테로이드성 진통소염제를 사용해서 증상이 호전된 증례를 경험하여 문헌 고찰과 함께 보고하는 바이다.

다국어 초록 (Multilingual Abstract)

Several autoimmune and chronic inflammatory conditions have been consistently linked with an increased risk of hematologic malignancies. Although ankylosing spondylitis (AS) is a chronic inflammatory disease, previous studies have demonstrated that it is not associated with an increase in risk of malignant lymphomas. Cases of AS accompanied by hematologic malignancies such as multiple myeloma, chronic myelogenous leukemia, and Hodgkin`s disease have been reported. In Korea, AS with non-Hodgkin`s lymphoma or follicular lymphoma has not been reported. We experienced a 38-year-old male who had been diagnosed with follicular lymphoma with bone metastasis, who achieved complete remission after having been treated with chemotherapy, developed new inflammatory back pain. An MRI of his hip showed an active inflammation of the left sacroiliac joint and a positive HLA-B27. The patient was diagnosed with AS and was treated with naproxen, which improved the pain in his back and buttock.

참고문헌 (Reference)

1 최우형, "강직성척추염에 동반된 만성 골수성백혈병 1예" 대한류마티스학회 17 (17): 417-421, 2010

2 Zintzaras E, "The risk of lymphoma development in autoimmune diseases: a meta-analysis" 165 : 2337-2344, 2005

3 Hyung-Il Moon, "The Association between Multiple Myeloma and Ankylosing Spondylitis: A Report of Two Cases" 대한혈액학회 44 (44): 182-187, 2009

4 Au WY, "Risk of haematological malignancies in HLA-B27 carriers" 115 : 320-322, 2001

5 Askling J, "Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study" 65 : 1184-1187, 2006

6 Park DJ, "Hodgkin’s disease developed in a patient with ankylosing spondylitis" 48 : 531-535, 1995

7 Askling J, "Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists" 64 : 1414-1420, 2005

8 Sant M, "HAEMACARE Working Group. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project" 116 : 3724-3734, 2010

9 van der Linden S, "Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria" 27 : 361-368, 1984

10 Song IH, "Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial" 62 : 1290-1297, 2010

11 Chang MH, "Clinical features and treatment outcomes of adult B-and T-lymphoblastic lymphoma: results of multicentre analysis in Korea" 50 : 1119-1125, 2009

12 Calin A, "Back pain: mechanical or inflammatory" 20 : 97-100, 1979

13 Ekström Smedby K, "Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium" 111 : 4029-4038, 2008

14 Smedby KE, "Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update" 264 : 514-527, 2008

15 Baecklund E, "Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis" 54 : 692-701, 2006